
Well, CPhI has certainly been keeping me busy, yesterday involved a whole raft of press conferences and the trek round the conference centre, before dashing back to the hotel to freshen up quickly before going to the annual European Fine Chemicals Group dinner where Ben Thorpe, managing director Healthcare at Goldman Sachs, gave an enthralling after dinner speech about the state of the pharmaceutical industry - and how that affects fine chemical producers.
During the day I spoke to a plethora of companies and had the opportunity to sit down and chat with Gilles Cottier, president of SAFC - who just happened to be serving coffee to visitors to the stand when I turned up! While he predicts SAFC will see low single digit sales growth across the whole year, he is cautious about the outlook for the fine chemical industry in general as consumer confidence is still fragile.
I also got to chat with UK firm Manchester Organics, which specialises in making fluorinated organic molecules for the pharma and agrochem industries. Simon Clayton, director and one of two founders of the company, told me that despite the recession the business was seeing solid growth and it had recently invested around £0.5 million on buying new pressure vessels to conduct the fluorination reactions in and was also moving into microwave synthesis. One of the reasons he gave for the company’s growth was that ‘no one else will touch the fluorinating agent SF4 as it’s just too dangerous!’
Today I got to chat to Tony Bastock, group managing director of UK-based Contract Chemicals, who told me that the company had had its best year in the last ten - and had revenues of over £25 million, with 65 per cent of those sales coming from exports. The firm, which started as a specialist in bromination chemistry, uses around 2000 tonnes of bromine a year, even thought it now makes a while range of intermediates for pharmaceutical and agrochemical customers.
Well, it’s getting close to that time where I need to head to the airport - and as they say round here: gracias por todo, hasta la vista.
Matt Wilkinson